FDA
approval
· 2017-11-08
FDA Approved: PREVYMIS — Original Application (Merck Sharp & Dohme LLC)
Summary
The FDA approved PREVYMIS (letermovir) in an original application for the prophylaxis of cytomegalovirus infection in CMV-seropositive adult recipients of allog…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PREVYMIS (LETERMOVIR)